Dimier, N. (2018). A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationDimier, N. A Model for Predicting Effect of Treatment on Progression-free Survival Using MRD as a Surrogate End Point in CLL. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationDimier, N. A Model for Predicting Effect of Treatment on Progression-free Survival Using MRD as a Surrogate End Point in CLL. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.